Signaling pathways involved in induction of GADD45 gene expression and apoptosis by troglitazone in human MCF-7 breast carcinoma cells

Oncogene

Volumn 23, Issue 26, 2004, Pages 4614-4623

  Yin, Fen ^a   Bruemmer, Dennis ^a   Blaschke, Florian ^a   Hsueh, Willa A ^a   Law, Ronald E ^a   Van Herle, Andre J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer cell; ERK1 2; GADD45; JNK; p38; Troglitazone

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PIOGLITAZONE; ROSIGLITAZONE; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TROGLITAZONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTINEOPLASTIC AGENT; CHROMAN DERIVATIVE; ENZYME INHIBITOR; FLAVONOID; IMIDAZOLE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN; PYRIDINE DERIVATIVE; SIGNAL PEPTIDE; SMALL INTERFERING RNA;

ARTICLE; BREAST CARCINOMA; CARCINOMA CELL; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; DOSE RESPONSE; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; UPREGULATION; APOPTOSIS; BREAST TUMOR; CARCINOMA; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY;

MINK CELL FOCUS-FORMING VIRUS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CARCINOMA; CELL CYCLE; CHROMANS; ENZYME INHIBITORS; FEMALE; FLAVONOIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMIDAZOLES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROMOTER REGIONS (GENETICS); PROTEINS; PYRIDINES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; THIAZOLIDINEDIONES; TUMOR CELLS, CULTURED;

EID: 3042630489     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207598     Document Type: Article

References (47)

1. Asou H, Verbeek W, Williamson E, Elstner E, Kubota T, Kamada N and Koeffler HP. (1999). Int. J. Oncol., 15, 1027-1031.
2. Bae MA and Song BJ. (2003). Mol. Pharmacol., 63, 401-408.
3. Begum NM, Nakashiro K, Kawamata H, Uchida D, Shintani S, Ikawa Y, Sato M and Hamakawa H. (2002). Int. J. Oncol., 20, 599-605.
4. Bruemmer D, Yin F, Liu J, Berger JP, Sakai T, Blaschke F, Fleck E, Van Herle AJ, Forman BM and Law RE. (2003). Circ. Res., 93, 38-47.
5. Carrier F, Georgel PT, Pourquier P, Blake M, Kontny HU, Antinore MJ, Gariboldi M, Myers TG, Weinstein JN, Pommier Y and Fornace Jr. AJ. (1999). Mol Cell Biol, 19, 1673-1685.
6. Chang TH and Szabo E. (2000). Cancer Res., 60, 1129-1138.
7. Chen C. (1998). Am. J. Health Syst. Pharm., 55, 905-925.
8. Chen F, Zhang Z, Leonard SS and Shi X. (2001). Oncogene, 20, 3585-3589.
9. Chen IT, Smith ML, O'Connor PM and Fornace Jr. AJ. (1995). Oncogene, 11, 1931-1937.
10. Chitturi S and George J. (2002). Semin. Liver Dis., 22, 169-183.
11. Clay CE, Namen AM, Atsumi G, Willingham MC, High KP, Kute TE, Trimboli AJ, Fonteh AN, Dawson PA and Chilton FH. (1999). Carcinogenesis, 20, 1905-1911.
12. Demetri GD, Fletcher CD, Mueller E, Sarraf P, Naujoks R, Campbell N, Spiegelman BM and Singer S. (1999). Proc. Natl. Acad. Sci. USA, 96, 3951-3956.
13. Elstner E, Muller C, Koshizuka K, Williamson EA, Park D, Asou H, Shintaku P, Said JW, Heber D and Koeffler HP. (1998). Proc. Natl. Acad. Sci. USA, 95, 8806-8811.
14. Finkel T and Holbrook NJ. (2000). Nature, 408, 239-247.
15. Fujiwara T, Yoshioka S, Yoshioka T, Ushiyama I and Horikoshi H. (1988). Diabetes, 37, 1549-1558.
16. Haydon RC, Zhou L, Feng T, Breyer B, Cheng H, Jiang W, Ishikawa A, Peabody T, Montag A, Simon MA and He TC. (2002). Clin. Cancer Res., 8, 1288-1294.
17. Hisatake JI, Ikezoe T, Carey M, Holden S, Tomoyasu S and Koeffler HP. (2000). Cancer Res., 60, 5494-5498.
18. Huin C, Schohn H, Hatier R, Bentejac M, Antunes L, Plenat F, Bugaut M and Dauca M. (2002). Biol. Cell, 94, 15-27.
19. Kearsey JM, Coates PJ, Prescott AR, Warbrick E and Hall PA. (1995). Oncogene, 11, 1675-1683.
20. Kostrubsky VE, Sinclair JF, Ramachandran V, Venkataramanan R, Wen YH, Kindt E, Galchev V, Rose K, Sinz M and Strom SC. (2000). Drug Metab. Dispos., 28, 1192-1197.
21. Kubota T, Koshizuka K, Williamson EA, Asou H, Said JW, Holden S, Miyoshi I and Koeffler HP. (1998). Cancer Res., 58, 3344-3352.
22. Kultz D, Madhany S and Burg MB. (1998). J. Biol. Chem., 273, 13645-13651.
23. Lowell BB. (1999). Cell, 99, 239-242.
24. Mita H, Tsutsui J, Takekawa M, Witten EA and Saito H. (2002). Mol. Cell Biol., 22, 4544-4555.
25. Mossner R, Schulz U, Kruger U, Middel P, Schinner S, Fuzesi L, Neumann C and Reich K. (2002). J. Invest. Dermatol., 119, 576-582.
26. Mueller E, Sarraf P, Tontonoz P, Evans RM, Martin KJ, Zhang M, Fletcher C, Singer S and Spiegelman BM. (1998). Mol. Cell, 1, 465-470.
27. Osawa E, Nakajima A, Wada K, Ishimine S, Fujisawa N, Kawamori T, Matsuhashi N, Kadowaki T, Ochiai M, Sekihara H and Nakagama H. (2003). Gastroenterology, 124, 361-367.
28. Otto C, Lehrke M and Goke B. (2002). Pharmacogenomics, 3, 99-116.
29. Palakurthi SS, Aktas H, Grubissich LM, Mortensen RM and Halperin JA. (2001). Cancer Res., 61, 6213-6218.
30. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ and Davis RJ. (1995). J. Biol. Chem., 270, 7420-7426.
31. Rishi AK, Sun RJ, Gao Y, Hsu CK, Gerald TM, Saeed Sheikh M, Dawson MI, Reichert U, Shroot B, Fornace Jr. AJ, Brewer G and Fontana JA. (1999). Nucleic Acids Res., 27, 3111-3119.
32. Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D, Hunt T and Nebreda AR. (1994). Cell, 78, 1027-1037.
33. Rumi MA, Sato H, Ishihara S, Kawashima K, Hamamoto S, Kazumori H, Okuyama T, Fukuda R, Nagasue N and Kinoshita Y. (2001). Br. J. Cancer, 84, 1640-1647.
34. Sakaue M, Adachi H and Jetten AM. (1999). Mol. Pharmacol, 55, 668-676.
35. Sarkar D, Su ZZ, Lebedeva IV, Sauane M, Gopalkrishnan RV, Valerie K, Dent P and Fisher PB. (2002). Proc. Natl. Acad. Sci. USA, 99, 10054-10059.
36. Sarraf P, Mueller E, Jones D, King FJ, DeAngelo DJ, Partridge JB, Holden SA, Chen LB, Singer S, Fletcher C and Spiegelman BM. (1998). Nat. Med., 4, 1046-1052.
37. Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM, Kastan MB, O'Connor PM and Fornace Jr. AJ. (1994). Science, 266, 1376-1380.
38. Spiegelman BM. (1998). Diabetes, 47, 507-514.
39. Sugimura A, Kiriyama Y, Nochi H, Tsuchiya H, Tamoto K, Sakurada Y, Ui M and Tokumitsu Y. (1999). Biochem. Biophys. Res. Commun., 261, 833-837.
40. Takahashi S, Saito S, Ohtani N and Sakai T. (2001). Cancer Res., 61, 1187-1195.
41. Takashima T, Fujiwara Y, Higuchi K, Arakawa T, Yano Y, Hasuma T and Otani S. (2001). Int. J. Oncol., 19, 465-471.
42. Takekawa M and Saito H. (1998). Cell, 95, 521-530.
43. Tong T, Fan W, Zhao H, Jin S, Fan F, Blanck P, Alomo I, Rajasekaran B, Liu Y, Holbrook NJ and Zhan Q. (2001). Exp. Cell Res., 269, 64-72.
44. Wang X, Gorospe M and Holbrook NJ. (1999). J. Biol. Chem., 274, 29599-29602.
45. Yang WL and Frucht H. (2001). Carcinogenesis, 22, 1379-1383.
46. Yin F, Wakino S, Liu Z, Kim S, Hsueh WA, Collins AR, Van Herle AJ and Law RE. (2001). Biochem. Biophys. Res. Commun., 286, 916-922.
47. Yoshizawa K, Cioca DP, Kawa S, Tanaka E and Kiyosawa K. (2002). Cancer, 95, 2243-2251.